46 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
party if Gimoti is subject to a safety recall; if the other party is in breach of certain regulatory compliance representations under the agreement … to maintain cGMP compliance.
Once an approval is granted, FDA may suspend, restrict or withdraw the approval, require a product recall, or impose additional
8-K
EX-1.1
kv9tb3q6k
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm